VYAIRE MEDICAL, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	1	1
2022	—	4	1
2021	—	4	1
2020	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
Polsinelli PC	—	14

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Federal Emergency Management Agency (FEMA)	10
Food & Drug Administration (FDA)	10
HOUSE OF REPRESENTATIVES	10
SENATE	10
Health & Human Services, Dept of (HHS)	8
Vice President of the U.S.	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	11

Bills Explicitly Cited (2)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 3799117th Congress

PREVENT Pandemics Act

2022 · second_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act

Client expense: — · Firm income: $50,000

Matched citations: S.3799

S. 3799117th Congress

PREVENT Pandemics Act

2022 · first_quarter · Firm: Polsinelli PC

Open original LDA filing ↗

Cited source text and reported amounts

-Legislation related to the Covid-19 Pandemic and ventilator production -Legislation related to strengthening the supply chain -Issues related to readiness of Strategic National Stockpile -S.3799 PREVENT Pandemics Act

Client expense: — · Firm income: $80,000

Matched citations: S.3799

Source: Senate LDA

VYAIRE MEDICAL, INC. — Lobbying Disclosure | Poliscope